19 January 2021
A new national research project to study the effects of emerging mutations in SARS-CoV-2 will be launched with £2.5 million funding from UK Research and Innovation (UKRI).
31 December 2020
Congratulations to Sir Dave Stuart, FRS FMedSci, NDM’s Professor of Structural Biology, knighted for services to medical research and the scientific community.
30 December 2020
The Nuffield Department of Medicine welcomes the news that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK.
16 December 2020
Susie Dunachie joins a prestigious group of leading health researchers in the latest cohort of NIHR Global Research Professors. These awards fund research leaders of the future to promote effective translation of research and to strengthen health, public health and care research leadership at the highest academic levels. Research conducted by Global Research Professors directly benefits people in LMICs. A Consultant in Infectious Diseases and Medical Microbiology, Susie works on the development of a vaccine to prevent death from melioidosis in people with type 2 diabetes mellitus in LMICs, and supports vaccine research in Thailand.
14 December 2020
RECOVERY reports absence of a benefit from Azithromycin. The latest result from the NDM/NDPH RECOVERY trial shows the widely administered administration of a broad-spectrum antibiotic makes no difference to the routine outcome in hospitalised COVID19 disease. Results on other therapies are likely to follow in the coming weeks.
11 December 2020
Data from the National COVID-19 Infection Survey, done in partnership between the University of Oxford, the Office of National Statistics, Public Health England, University of Manchester and the Wellcome Trust, has revealed detailed characteristics of England’s coronavirus pandemic, including which factors have contributed most to case numbers over different phases and the prevalence of asymptomatic infections.
First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
9 December 2020
Today, the University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%. The new study published in the Lancet is the first peer-reviewed publication of phase 3 data from studies of a vaccine against the coronavirus.
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
30 October 2020
Kenya has joined the global efforts in search of an effective vaccine for COVID-19 with the start of a trial evaluating the ChAdOx1 nCoV-2019 Oxford coronavirus vaccine. Following the necessary approvals from regulators, as well as the national ministry of health, and Kilifi county, the first volunteers for the trial have recently received their vaccinations.
29 October 2020
The University's latest Recognition of Distinction Exercise has awarded the Nuffield Department of Medicine three new Professors; Elisabeth Ashley - Professor of Tropical Medicine. Stuart Blacksell - Professor of Tropical Microbiology and John B Davis - Professor of Pharmaceutical Discovery.
23 October 2020
Following the announcement in June of a new philanthropic relationship between Bvlgari and the University of Oxford, Bvlgari’s donation in support of DPhil students in vaccine research benefits two exceptional students, appointed as the first cohort of Bvlgari Scholars. The Jenner Institute welcomes students Cameron Bissett and Rebecca Makinson this month for the start of their DPhil courses, after demonstrating remarkable academic potential and merit in the field of vaccine-related immunology.
New partnership with The Alan Turing Institute and Royal Statistical Society to support Joint Biosecurity Centre COVID-19 response
21 October 2020
Prof Chris Holmes, The Alan Turing Institute’s Programme Director of Health and Medical Science, and Professor of Biostatistics at the Nuffield Department of Medicine, said: “The Turing is delighted to be playing a pivotal role in supporting the JBC by working to build an alliance with the RSS and academic experts to provide new insights in the evolving fight against COVID-19. In doing so, we will strengthen knowledge across the wider public health ecosystem."
16 October 2020
Thousands of lives could be saved by measuring the strength of the antibody response in those who have had the virus and how long their immunity may last for. Professor Paul Klenerman and his team at the University of Oxford have partnered with Oxford University Hospitals NHS Foundation Trust (OUH) to test thousands of healthcare workers.
12 October 2020
Congratulations to Simon Leedham BSc PhD QMUL, MB BS London, FRCP, Professor of Gastroenterology and Wellcome Trust Senior Research Fellow in Clinical Science in the Wellcome Trust Centre for Human Genetics, has been appointed to the Professorship of Molecular and Population Genetics in the Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine. He took up the post on 1 October 2020 and will be a Fellow of Queen's College, Oxford.
12 October 2020
Prof Walker was recognised for services to academia and the COVID-19 response. Sarah is also the chief investigator and academic lead for the National Covid-19 Infection Survey, a collaboration between the University and the Office for National Statistics (ONS), investigating prevalence and incidence of current and past infections of the virus in the UK.
Comparison of five tests used to detect COVID-19 antibodies shows Siemens and Oxford assays met regulatory targets
28 September 2020
New research shows that, in a head-to-head comparison of five tests used to detect COVID-19 antibodies (known as ‘immunoassays’), an assay manufactured by Siemens and one developed by an academic partnership led by the University of Oxford had the most accurate results. The study is published in The Lancet Infectious Diseases.
25 September 2020
Scientists from the University of Oxford’s Nuffield Department of Medicine have today published their evaluation of LamPORE, a novel diagnostic platform for detecting SARS-CoV-2 RNA. It combines loop-mediated isothermal amplification with nanopore sequencing. This technology has the potential to analyse thousands of samples per day on a single instrument.